As a South African reader, I find the UK’s outrage over digital ID rather quaint — a little like watching someone panic about electricity while clutching a torch (“Starmer gives green light to digital ...
Contrary to what was written in your magazine feature “The agony and ecstasy of restoring Fra Angelico” (Spectrum, October 4), the Arno did not “unexpectedly burst its banks” in 1966. After a long ...
Simon Kuper’s article (Spectrum, Life & Arts, October 4) attributes moguls’ longevity to “innovations like stem-cell therapy and blood washing”. However, there is no scientific evidence for these ...
The review of Jill Lepore’s book We the People (“Have Americans got their constitution all wrong?”, September 27) does not ...
But design can ameliorate everyday life by improving products that will then give more pleasure in use, and perhaps be used for longer. Unfortunately it is not plausible to think that design itself ...
I have to take issue with the framing of the HTSI article by Mark C O’Flaherty (“Devil in the details”, September 27), which discusses what he calls “villainy in menswear”, invoking German attire of ...
Simon Schama’s Weekend Essay “Lessons in liberty” is right: we have forgotten the subtle but vital distinction between ...
Chancellor Rachel Reeves has urged business leaders to start talking up Britain or risk letting Nigel Farage into Downing ...
When HSBC unveiled a $13.6bn deal to take full control of its local Hong Kong lender on Thursday, chief executive Georges Elhedery was clear: after a year spent in retreat from high-profile businesses ...
Hey you wise guys at Jonathan Cape and Penguin Press, I know I’m a slow learner but how can you be sure that the PDF that ...
Your guide to what Trump’s second term means for Washington, business and the world The US will allow Qatar to build an air force facility at an American military base in the western state of Idaho, ...
AstraZeneca has agreed to lower costs of some medicines in exchange for a three-year reprieve from US President Donald Trump’s tariffs. As part of the deal the pharmaceutical company will cut drug ...